Kymera Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $2.2M | 81k | 27.37 |
| 2024-12-31 | $2.6M | 64k | 40.23 |
| 2024-09-30 | $1.6M | 35k | 47.33 |
| 2024-06-30 | $585k | 20k | 29.86 |
| 2024-03-31 | $8.9M | 221k | 40.20 |
| 2023-12-31 | $2.3M | 89k | 25.46 |
| 2023-09-30 | $1.4M | 101k | 13.88 |
| 2023-03-31 | $6.1M | 205k | 29.63 |
| 2022-12-31 | $3.3M | 132k | 24.96 |
| 2022-09-30 | $3.0M | 201k | 14.93 |
| 2021-12-31 | $5.2M | 82k | 63.49 |
| 2021-03-31 | $2.5M | 64k | 38.86 |
| 2020-12-31 | $126k | 2.0k | 62.01 |